In contrast to other cytotoxic agents including anthracyclins and oxaliplatin (OXP), cisplatin (CDDP) fails to induce immunogenic tumor cell death that would allow to stimulate an anticancer immune response and hence to amplify its therapeutic efficacy. This failure to induce immunogenic cell death can be attributed to CDDP's incapacity to elicit the translocation of calreticulin (CRT) from the lumen of the endoplasmic reticulum (ER) to the cell surface. Here, we show that, in contrast to OXP, CDDP is unable to activate the protein kinase-like ER kinase (PERK)-dependent phosphorylation of the eukaryotic translation initiation factor 2a (eIF2a). Accordingly, CDDP also failed to stimulate the formation of stress granules and macroautophagy, two processes that only occur after eIF2a phosphorylation. Using a screening method that monitors the voyage of CRT from the ER lumen to the cell surface, we identified thapsigargin (THAPS), an inhibitor of the sarco/ER Ca 2 þ -ATPase as a molecule that on its own does not stimulate CRT exposure, yet endows CDDP with the capacity to do so. The combination of ER stress inducers (such as THAPS or tunicamycin) and CDDP effectively induced the translocation of CRT to the plasma membrane, as well as immunogenic cell death, although ER stress or CDDP alone was insufficient to induce CRT exposure and immunogenic cell death. Altogether, our results underscore the contribution of the ER stress response to the immunogenicity of cell death.
In contrast to other cytotoxic agents including anthracyclins and oxaliplatin (OXP), cisplatin (CDDP) fails to induce immunogenic tumor cell death that would allow to stimulate an anticancer immune response and hence to amplify its therapeutic efficacy. This failure to induce immunogenic cell death can be attributed to CDDP's incapacity to elicit the translocation of calreticulin (CRT) from the lumen of the endoplasmic reticulum (ER) to the cell surface. Here, we show that, in contrast to OXP, CDDP is unable to activate the protein kinase-like ER kinase (PERK)-dependent phosphorylation of the eukaryotic translation initiation factor 2a (eIF2a). Accordingly, CDDP also failed to stimulate the formation of stress granules and macroautophagy, two processes that only occur after eIF2a phosphorylation. Using a screening method that monitors the voyage of CRT from the ER lumen to the cell surface, we identified thapsigargin (THAPS), an inhibitor of the sarco/ER Ca 2 þ -ATPase as a molecule that on its own does not stimulate CRT exposure, yet endows CDDP with the capacity to do so. The combination of ER stress inducers (such as THAPS or tunicamycin) and CDDP effectively induced the translocation of CRT to the plasma membrane, as well as immunogenic cell death, although ER stress or
Introduction
Cell death can be classified according to the morphological appearance of the lethal process (that may be apoptotic, necrotic, autophagic or associated with mitosis), enzymological criteria (with and without the involvement of nucleases or distinct classes of proteases, like caspases), functional aspects (programmed or accidental, physiological or pathological) or immunological characteristics (immunogenic or non-immunogenic) . Thanks to the advancing comprehension of cellular demise, it has become clear that the textbook equation 'programmed cell death-¼ apoptosis ¼ caspase activation ¼ non-immunogenic cell death', although applicable to some instances of cell death, constitutes an incorrect generalization, at several levels (Garg et al., 2009; Green et al., 2009) . Thus, necrosis can be programmed both in its course and its occurrence (Vandenabeele et al., 2008) . Apoptosis can be lethal without caspase activation, and caspase activation does not necessarily cause cell death (Kroemer and Martin, 2005) . Finally, cell death with an apoptotic appearance can be immunogenic (Casares et al., 2005) . These examples illustrate the urgent need for a more detailed comprehension of cell death subroutines.
We define cell death as 'immunogenic' if dying cells that express a specific antigen (such as the model antigen ovalbumin or tumor antigens), yet are uninfected (and hence lack pathogen-associated molecular patterns) and are injected subcutaneously into mice, in the absence of any adjuvant, elicit a protective immune response (Casares et al., 2005) . Such a protective immune response precludes the growth of living transformed cells expressing the specific antigen injected into mice. At least one form of immunogenic cell death, the one induced by anthracyclines and oxaliplatin (OXP), is characterized by the early cell surface exposure of chaperones including calreticulin (CRT) and/or heat shock proteins, which determine the uptake of tumor antigens and/or affect dendritic cell (DC) maturation (Spisek et al., 2007; Obeid et al., 2007b) . The later release of the protein high mobility group box 1, which acts on Toll-like receptor 4 on the surface of DC, is required for optimal presentation of antigens from dying tumor cells (Apetoh et al., 2007) . Moreover, the release of adenosine triphosphate (ATP) from dying tumor cells stimulates purinergic P2RX7 receptors on the surface of DC to stimulate the production of an essential cytokine, interleukin-1 (Ghiringhelli et al., 2009) . Hence, CRT, high mobility group box 1 and ATP compose some of the 'dents' of the 'key' that unlocks the immune response (Zitvogel et al., 2010) . We know that each of these 'dents' is required for the immunogenicity of cell death.
The translocation of intracellular CRT (endo-CRT) to the plasma membrane surface (ecto-CRT) occurs relatively early (before exposure of phosphatidylserine) and is critical for the recognition and engulfment of dying tumor cells by dendritic cells (Obeid et al., 2007a) . Thus, anthracyclines and OXP that induce ecto-CRT cause immunogenic cell death, whereas other proapoptotic agents (such as etoposide, mitomycin C and cisplatin (CDDP)) induce neither ecto-CRT nor immunogenic cell death (Casares et al., 2005; Obeid et al., 2007b) . Depletion of CRT abolishes the immunogenicity of cell death elicited by anthracyclines, whereas exogenous supply of CRT can enhance the immunogenicity of cell death (Obeid et al., 2007a) . The immunogenicity of cell death is not only relevant to the vaccination of mice with dying cells; it actually can determine the chemotherapeutic response of established tumors. Thus, anthracycline-based chemotherapies inhibit the growth of control tumors growing on immunocompetent mice, yet lose their therapeutic efficacy on the same tumors implanted into immunodeficient mice and even on tumors that grow on immunocompetent mice yet have been engineered to disrupt the CRT exposure pathway (Panaretakis et al., 2009) . Conversely, restoration of defective CRT exposure by injecting recombinant CRT into tumors treated with non-immunogenic cell death inducers (such as etoposide, mitomycin C and CDDP) can improve the efficacy of anticancer chemotherapies (Obeid et al., 2007b; Tesniere et al., 2010) .
These results have prompted our interest in characterizing the CRT exposure pathway in some detail. CRT is usually located in the lumen of the endoplasmic reticulum (ER), and it appears logical that the ER stress response elicited by chemotherapeutic agents participates in the CRT exposure pathway (Krause and Michalak, 1997) . The ER stress response is generally stimulated by unfolded proteins, which interact with the ER chaperone BiP (also called GRP78), causing the deinhibition of several factors that are normally neutralized by BiP, namely protein kinase-like ER kinase (PERK), inositol-requiring ER-to-nucleus signal kinase 1a and activating transcription factor 6 (Kaufman, 1999) . Among these three arms of the ER stress response, only PERK is relevant to CRT exposure (Obeid et al., 2007b) . PERK phosphorylates its substrate eukaryotic translation initiation factor 2a (eIF2a) on serine 51, thereby activating the integrated ER stress response that leads to translational arrest (Kaufman, 1999) , the formation of stress granules (Kedersha et al., 1999) , as well as macroautophagy (Orvedahl and Levine, 2009) . Cells in which wild-type eIF2a is replaced by the non-phosphorylatable S51A mutant fail to expose CRT in response to anthracyclins or OXP (Panaretakis et al., 2009) , underscoring the central importance for this ER stress response for the immunogenicity of cell death. Once the ER stress response has been activated, it can trigger the ER-proximal activation of caspase-8, which cleaves the ER protein BAP31, thereby unleashing a pathway that culminates in the anterograde transport of CRT from the ER to the Golgi apparatus and the active exocytosis of CRT, which then binds to the cell surface (Panaretakis et al., 2009) . A systematic mass spectrometric identification of plasma membrane proteins exposed on the surface of cells treated with anthracyclines led to the conclusion that only some ER proteins including CRT (Obeid et al., 2007b) , its co-factor ERp57 and the ER-associated lysyl-tRNA synthetase (KARS) but not other ER proteins (such as calnexin, sarco/ER Ca 2 þ -ATPase (SERCA) or IP 3 R) are translocated to the plasma membrane.
Here, we specifically addressed the question why CDDP-in contrast to the related compound OXPfails to induce immunogenic cell death. To answer this problem, we monitored several cell lines that express a series of cell death-relevant biosensors, allowing us to map the defect in the CRT exposure pathway elicited by CDDP. Furthermore, we designed a screening system allowing us to identify compounds that are inert with regard to apoptotic signaling, yet can restore CDDP's capacity to induce CRT exposure and to stimulate immunogenic cell death.
Results
Failure of CDDP to induce CRT redistribution from the ER lumen to the cell surface To monitor the redistribution of CRT from the ER lumen to peripheral locations close to the plasma membrane, we generated U2OS cells that stably express a CRT-green fluorescent protein (GFP) fusion protein (Snapp et al., 2006) . Control experiments revealed that this protein was located in the ER lumen, in which most of the endogenous CRT resides (not shown). On treatment with two immunogenic cell death inducers, mitoxantrone and OXP, CRT-GFP relocates from a preponderantly perinuclear, near-to-diffuse location (which is seen in untreated control cells) to a more peripheral, spot-like ('granular') distribution (Figure 1a ). This increased 'granularity', which can be quantified using morphometric image analysis software (Rello-Varona et al., 2010) , is observed after treatment of the cells with mitoxantrone or OXP, but not after treatment with CDDP (Figures 1a and b) . Nonetheless, CDDP-induced chromatin condensation, the morphological hallmark of apoptosis as efficiently as mitoxantrone or OXP (percentage values in Figure 1b , representative image in Supplementary Figure 1) . Indeed, pairwise comparisons were always performed at the IC 50 of both agents, which was B600 mM for OXP and B150 mM for CDDP in short-term experiments measuring imminent cell death (as indicated by a loss of the mitochondrial transmembrane potential, DC m , see below). Surface immunofluorescence staining confirmed that a subset of the OXP-elicited CRT-GFP granules that were close to the cell surface, extruded CRT-GFP, which became accessible to a GFP-specific antibody (revealed in red). Again, no immunodetectable CRT was found on the surface of non-permeabilized cells treated with CDDP ( Figure 1c ). In U2OS cells expressing CRT-GFP, the intracellular redistribution of CRT preceded that of its surface exposure as assessed by immunostaining with a CRT-specific antibody ( Figure 1d ).
Immunofluorescence detection of CRT requires several washing steps that might perturb the integrity of cells. 
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To avoid this problem, we generated a chimeric protein that contains CRT in its N-terminus and the HaloTag moiety in its C-terminus followed by the KDEL (lys-aspglu-leu) ER retention signal ( Figure 1e ). This construct could be labeled with commercially available HaloTag ligands, which are either cell-impermeable (as exemplified by HaloTag Alexa Fluor 488 ligand, green fluorescence) or cell-permeable (as exemplified by HaloTag TMR ligand, red fluorescence) (Figures 1f  and g ). The CRT-HaloTag fusion protein underwent a similar intracellular redistribution (detected by staining with membrane permeable HaloTag TMR) as did CRT-GFP when the cells were treated with mitoxantrone (not shown) or OXP ( Figure 1g ). Moreover, U2OS cells expressing the CRT-HaloTag fusion protein did not stain with the cell-impermeable HaloTag Alexa Fluor 488 ligand, unless they were treated with immunogenic cell death inducers such as OXP ( Figure 1g ). CDDP failed to induce the surface exposure of CRT-HaloTag, as determined by fluorescence microscopy ( Figure 1g ) or cytofluorometric analysis of HaloTag Alexa Fluor 488 ligand-stained cells (Figure 1h ). CRT-HaloTag distributed to discrete microdomains on the cell surface, which is in accordance with studies on endogenous CRT distribution during immunogenic cell death . In conclusion, CDDP is unable to induce CRT exposure in conditions in which it does induce nuclear apoptosis.
Failure of CDDP to elicit ER stress When used at their IC 50 , CDDP and OXP had a comparable potency in inducing nuclear apoptosis (see above). Moreover, both agents were able to induce mitochondrial perturbations that were measured by two different methods. First, we determined the DC m dissipation by means of the DC m -sensitive fluorochrome 3,3 dihexyloxacarbocyanine iodide (DiOC 6 (3)) ( Figures  2a and b) . Second, we assessed the relocation of a Bax-GFP fusion protein (von Haefen et al., 2004) from Thapsigargin restores immunogenic cancer cell death I Martins et al a diffuse to a punctate (presumably mitochondrial) pattern (Figures 2c and d) . Thus, both CDDP and OXP induced similar mitochondrial perturbations (Figure 2 ). Moreover, both agents induced a similar release of ATP, which is one of the obligatory signals linked to immunogenic cell death (Ghiringhelli et al., 2009 ). This result was obtained using two different methods, namely staining of the cells with the ATP-sensitive fluorochrome quinacrine (Figures 3a and b) , by measuring the residual ATP content within the cells (Figure 3c ) or the ATP secreted into the supernatant by means of a luciferasebased assay (Figure 3d ). Thus, both CDDP and OXP lead to a similar perturbation in energy metabolism. However, OXP and CDDP were rather different in their capacity to elicit the redistribution of G3BP-GFP (Tourriere et al., 2003) or GFP-LC3 (Kabeya et al., 2000) from a diffuse to a punctiform distribution, which indicates the formation of stress granules (Figures 4a and b) or autophagosomes (Figures 4c and d) , respectively. This difference was particularly remarkable at early time points. As mentioned in the Introduction section, the formation of stress granules and autophagosomes is subordinated to the obligate phosphorylation of eIF2a on serine 51, which is also required for the redistribution of CRT to the cell surface (Obeid et al., 2007b) . Indeed, OXP was much more efficient in inducing eIF2a phosphorylation, as determined by means of a phospho-neoepitope-specific antibody (Figure 4e ). Altogether, these results suggest that CDDP is much less efficient in inducing an ER stress response than OXP.
Identification of THAPS as an agent that reestablishes CRT relocalization in response to CDDP To identify compounds that might restore the defective CRT exposure pathway in tumor cells responding to CDDP, we conducted a high-content screen. This screen was based on the utilization of the Harvard Medical School Institute of Chemistry and Cell Biology (ICCB) library whose 480 components (Supplementary Table 1) were individually tested for their capacity to stimulate the redistribution of CRT-GFP in U2OS cells that were either left untreated or cultured for 4 h in the presence of 150 mM CDDP. When the results obtained in the absence and in the presence of CDDP were plotted for each compound individually, one single agent, thapsigargin (THAPS), was identified as being particularly efficient in inducing CRT-GFP granularity in the presence (but not in the absence) of CDDP (Figures 5a and b) . This result was confirmed in several independent determinations on U2OS cells expressing CRT-GFP (Figure 5c ). The treatment of U2OS cells with THAPS restored the ER stress response in CDDP-treated cells, as detected by a phospho-neoepitope-specific eIF2a antibody, the induction of stress granules and the formation of Figure 2E) . Moreover, THAPS restored CRT exposure by mitomycin C, an agent that induces non-immunogenic cell death and fails to stimulate CRT exposure when used alone (Supplementary Figure 5) . These results underscore the capacity of THAPS to stimulate CRT exposure in cancer cells that are exposed to distinct cytotoxic agents. 
Restoration of the immunogenicity of CDDP-induced cancer cell death by ER stress Confirming the strong correlation between CRT exposure and immunogenicity, CDDP-treated MCA205 cells were inefficient in inducing a protective anticancer immune response when injected subcutaneously into immunocompetent C57BL/6 mice 1 week before rechallenge with live tumor cells, in conditions in which OXP-treated MCA205 cells readily induced such a tumor-protective response (which precludes the growth of live MCA205 cells). However, the vaccine of dying cells that was generated in the presence of CDDP plus THAPS, elicited an effective anticancer immune response in vivo (Figure 6f ). To generalize these findings to other ER stress inducers, we investigated whether tunicamycin (TUNICA) would restore the immunogenicity of CDDP-killed cells as well. Consistently, the combination of CDDP and TUNICA was more efficient in inducing CRT than either of the two compounds alone (Figures 7a and b) . Accordingly, the combination of CDDP and TUNICA (but neither of them alone) stimulated immunogenic cell death, as assessed in vaccination experiments (Figure 7c ). In conclusion, the ER-stressors THAPS and TUNICA can reestablish both the defective CRT exposure and the defective immunogenicity of CDDP-induced cell death.
Discussion
The results shown in this paper confirm and extend our previous observation , that CDDP is rather different from another, closely related platinum compound, OXP in thus far that it is unable to induce CRT exposure. As briefly alluded to in the Introduction section, OXP elicits CRT exposure through a complex pathway that involves the sequential induction of an ER stress response accompanied by the PERK-mediated phosphorylation of eIF2a, caspase-8-mediated cleavage of the ER protein BAP31 and a final translocation process (Panaretakis et al., 2009) . Our results indicate that CDDP is unable to induce CRT exposure because, in contrast to OXP, it is unable to stimulate an ER stress response. Indeed, CDDP failed to stimulate the activation of PERK as well as the PERK-dependent phosphorylation of eIF2a, which is a central event of the integrated ER stress response (Harding et al., 1999) . Accordingly, CDDP was unable to trigger two additional eIF2a phosphorylation-dependent cellular events, namely the formation of stress granules and that of autophagosomes. In contrast, CDDP was readily able to perturb mitochondrial function, to induce nuclear apoptosis and to kill tumor cells, meaning that the apparent incapacity of CDDP to stimulate an ER Thapsigargin restores immunogenic cancer cell death I Martins et al stress response cannot be explained by its low cytocidal activity or an intrinsic CDDP resistance of the cell lines that we studied in this report. Rather, the intrinsic incapacity of CDDP to induce a full-blown ER stress response must be explained by hitherto enigmatic peculiarities of its chemical mode of action. Both CDDP and OXP are mostly considered as DNA-damaging agents. However, both CDDP and OXP can induce apoptosis-associated changes in cytoplasts (Gourdier et al., 2004; Yang et al., 2006) , that is, cells that have been enucleated, meaning that both of these agents have poorly characterized cytoplasmic targets, which must be at least in part agent-specific. We surmise that, in contrast to OXP, CDDP fails to affect the conformation of proteins that would cause an unfolded protein response in the ER, although the molecular details of this differential effect remain to be investigated. In accordance with the speculation that it is the deficient ER stress response that accounts for the incapacity of CDDP to stimulate CRT exposure, an unbiased screen that involved 480 distinct signal transduction modifiers led to the identification of one single molecule, THAPS that was able to reestablish CRT exposure by CDDP. THAPS is a prototypic inducer of ER stress (Booth and Koch, 1989 ) and a specific inhibitor of the SERCA. SERCA usually mediates the ATP-driven uptake of cytosolic Ca 2 þ into the ER lumen, meaning that its inhibition by THAPS causes a relative depletion of luminal Ca 2 þ (Lytton et al., 1991) . In this context it appears intriguing that previous investigations on human neuroblastoma cells that were defective in the anthracycline-elicited CRT exposure pathway, led to the conclusion that two manipulations designed to lower luminal ER Ca 2 þ , namely overexpression of reticulon 1C and targeted expression of the ligand-binding domain of the IP 3 receptor, both could bypass this defect and enhance CRT exposure (Tufi et al., 2008) . The data reported here underscore the importance of ER Ca 2 þ fluxes for the translocation of CRT to the cell surface. Nonetheless, it is important to note that other forms of ER stress such as that induced by TUNICA, which blocks the synthesis of all N-linked glycoproteins (N-glycans), thereby causing an unfolded stress response, also were able to induce CRT exposure in the context of CDDP. Thus, distinct ER stress inducers that share no chemical or functional similarity, like THAPS and TUNICA, can restore CRT exposure in the context of cytotoxic chemotherapeutics.
Although SERCA inhibition by THAPS could stimulate CRT exposure in the presence of CDDP, it failed to induce massive CRT exposure on its own, Thapsigargin restores immunogenic cancer cell death I Martins et al suggesting that CRT exposure requires the simultaneous engagement of (at least) two different cellular pathways, one that involves an ER stress response and another, unrelated one, which can be elicited by CDDP (or by mitomycin C). Whether this latter pathway is related to the DNA damage response (Delmastro et al., 1997) and/ or changes in redox metabolism (Tajeddine et al., 2008) elicited by CDDP is currently under investigation. Irrespective of these theoretical considerations, our data reveal the utility of several screening systems that we have developed, one that has been conceived to follow the voyage of CRT from the ER lumen to peripheral intracellular vesicles (by following the modification of CRT-GFP, which precedes its exposure) and the other one that has been designed to specifically detect the appearance of CRT on the surface of the stressed cell (by following CRT-HaloTag). We anticipate that these assays will eventually lead to the identification of effective CRT-exposing agents that can be employed either alone (if they have a tumoricidal potential) or in combination with cytotoxic agents to trigger immunogenic cancer cell death.
Materials and methods

Reagents and materials
Cell death was induced with mitoxantrone, CDDP (Sigma, St Louis, MO, USA) or OXP (Sanofi-Aventis, Paris, France). Quinacrine, staurosporine, NaHAsO 4 , THAPS, TUNICA as well as small interfering RNA oligonucleotides were purchased from Sigma. Rapamycin was from Tocris (Ellisville, MO, USA) and Z-VAD-fmk from Bachem (Bubendorf, Switzerland). Antibodies specific for eIF2a, phosphorylated eIF2a, b-actin, CRT and GADD45 were purchased from Cell Signaling (Beverly, MA, USA). The GFP antibody came from Santa Cruz (Santa Cruz, CA, USA). Cell culture media and selection antibiotics were from Gibco (Carlsbad, CA, USA). 3,3 dihexyloxacarbocyanine iodide (DIOC 6 (3)), propidium iodide (PI) and Hoechst 33342 were purchased from Invitrogen (Eugene, OR, USA).
Cell culture U2OS, 293FT and HeLa were cultured in Dulbecco's modified Eagle's medium supplemented with 10% (v/v) fetal calf serum, 1 mM sodium pyruvate and 10 mM Hepes buffer. CT26, Lewis lung cell carcinoma and MCA205 cells were grown in RPMI supplemented with identical components. U2OS clones were selected in the presence 1 mg/ml G418 (Gibco), 1 mg/ml Zeocin or 5 mg/ml blasticidine. Stable clones were cultured in the continuous presence of 200 mg/ml of G418 (Gibco), 200 mg/ml Zeocin or 1 mg/ml blasticidine. For RNA interference studies, the cells were transfected with small interfering RNA heteroduplexes specific for mouse CRT or human BAP31 (5 0 -CCGCUGGGUCGAAUCCAAA-3 0 ) and (5 0 -GCGCGAA AUUCGGAAGUAU-3 0 ) (Sigma-Proligo, The Woodlands, TX, USA) at a final concentration of 100 nM using HiPerFect (Qiuagen, Hilden, Germany). Unrelated small interfering RNA provided by Sigma-Proligo was used as control.
Viral transduction
Lentiviral particles for the transduction of cells with histone 2B-red fluorescent protein (H2B-RFP) were produced in 293FT cells by means of the ViraPower lentiviral expression system (Invitrogen). For this purpose, an H2B-RFP 
HaloTag-CRT stably expressing U2OS cells
The HaloTag sequence was amplified from a pHT2 plasmid (Promega, Madison, WI, USA) as NotI restriction fragment with the STOP codon removed from the HaloTag sequence. For the PCR amplification, the following primers were used: forward (5 0 -AAGCGGCCGCAATGGGATCCGAAATCGG TAC-3 0 ) reverse (5 0 -AAGCGGCCGCGCCGGCCAGCCCG GGGAGCC-3 0 ). PCR products were isolated on agarose gel, purified using the QIAquick Gel Extraction kit (Qiagen), and digested with the restriction enzyme NotI (New England Biolabs, Ipswich, MA, USA). The digested PCR product was ligated into the CRT-GFP plasmids at the NotI restriction site after removing the GFP sequence. Transfection of U2OS cells with the HaloTag-CRT was carried out with Lipofectamine 2000 (Invitrogen) following the manufacturer's instructions. Stable clones stably were selected by means of Zeocin selection.
CRT-GFP, Bax-GFP, G3BP-GFP, GFP-LC3 stably expressing U2OS cells U2OS cells were transfected by means of Lipofectamin 2000 with either CRT-GFP, Bax-GFP, G3BP-GFP or GFP-LC3 complementary DNA. Subsequently the cells were stably selected in G418 (Gibco). Individual resistant cells were sorted with a fluorescenceactivated cell sorting (FACS) vantage cell sorter into microtiter wells, and GFP-expressing clones were grown and selected. Some of these clones were further transduced with lentiviral particles expressing a H2B-RFP chimera using the ViraPowerLentiviral expression system (Invitrogen). H2B-RFP was cloned from a pmRFP-N1 vector (Clonetech, Mountain View, CA, USA) using the following primers: forward (5 0 -CACCATGCCAGAGCC AGCGAAG-3 0 ) and reverse (5 0 -TTAGGCGCCGGTGGAG TGGC-3 0 ). The PCR product was ligated into the pENTR/ D-TOPO vector by TOPO cloning technology (Invitrogen). The pENTR/D-TOPO vector, which contained the H2B-RFP gene, was recombined with the pLenti6/V5-DEST lentiviral expression vector using GATEWAY cloning technology (Invitrogen). The genes of interest were sequenced and virus particles were produced using the ViraPower Lentiviral Expression System (Invitrogen). The cells obtained by transduction were single cellsorted to identify double fluorescent clones.
Compound screen for CRT-exposing drugs and automated image analysis One day before the experiment, 5 Â 10 3 U2OS cells stably expressing CRT-GFP and H2B-RFP were seeded into 96-well Black/Clear Imaging Plates pre-treated with poly-L-lysine (BD Biosciences, San Jose, CA, USA). The ICCB known bioactives library (Enzo life science) was added at a concentration range from 90 nM to 48 mM in the presence or absence of 50 mM CDDP. Cells were incubated for 4 h at 37 1C and subsequently fixed with 4% paraformaldehyde for 20 min. After washing with phosphate-buffered saline (PBS), four view fields per well were acquired by means of an automated microscope (BD Pathway 855, Becton Dickinson, Mountain View, CA, USA). The images were segmented and analyzed for GFP granularity by comparing the standard deviation of the mean fluorescence intensity of groups of adjacent pixels within the cytoplasm of each cell to the mean fluorescence intensity in the same region of interest using the BD AttoVision software version 1.6 (BD Biosciences, San Jose, CA, USA). In parallel, the nuclear shape area was evaluated, and a threshold of 200 pixels (using a 20 Â objective) was set as cut off. Subsequently, the data were mined and statistically evaluated using Graph Pad.
To avoid inter-plate variations, the data were intra-plate normalized by calculating the ratio to untreated controls for each data point.
Cell death assays
In all, 6 Â 10 5 U2OS cells were treated with the indicated cell death inducers for 16 h at the indicated concentration. Cell death was quantified by cytofluorometric analysis using a FACS Vantage (Becton Dickinson), as described previously (Metivier et al., 1998; Patterson et al., 2000) . Cells were stained (30 min at 37 1C) with 3,3 dihexyloxacarbocyanine iodide (DiOC 6 (3); 40 nM) and PI (1 mg/ml) to determine the mitochondrial transmembrane potential and viability, respectively. Data were statistically evaluated using CellQuest Pro software (Becton Dickinson).
Quinacrine imunofluorescence U2OS cells were treated with the indicated cell death inducers for 16 h at the indicated concentrations. Subsequently, cells were labeled with quinacrine, as described (Martins et al., 2009) . In short, cells were labeled with 1 mM quinacrine in Krebs-Ringer solution (125 mM NaCl, 5 mM KCl, 1 mM MgSO 4 , 0,7 mM KH 2 PO 4 , 2mM CaCl 2 , 6mM glucose and 25 mM Hepes, pH 7.4) for 30 min at 37 1C. Thereafter, cells were stained with PI plus Hoechst 33342 (both 1 mg/ml) for 10 min, rinsed with Krebs-Ringer solution and fixed with 2% paraformaldehyde for 15 min at room temperature. Cells were examined with a BD Pathway 435 High-Content BioImager workstation (Becton Dickinson) by using a UApo/340 Â 20/ 0.75 objective (Olympus, Tokyo, Japan).
Quinacrine flow cytometry
In all, 6 Â 10 5 U2OS cells were treated with the cell death inducers for 24 h. After incubation in quinacrine solution (as above), cells were rinsed and resuspended in PBS containing 1 mg/ml PI. The samples were analyzed by means of a FACS Vantage (Becton Dickinson), and the data were statistically evaluated using the CellQuest Pro software (BD Biosciences). Dead (PI þ ) cells were excluded from the analysis.
ATP release assays
After cell death induction, extracellular ATP was measured by the luciferin-based ENLITEN ATP Assay (Promega). Intracellular ATP was measured using an ATP Assay kit (Calbiochem, Darmstadt, Germany) based on luciferinluciferase conversion. For assessment of the chemoluminescent signal, the plates were read in a Fluostar luminometer (BMG Labtech, Offenburg, Germany).
Analysis of surface exposed CRT Cells were cultured in the presence of the indicated agents for 4 h, washed twice and collected after overnight culture. For the HaloTag staining, cells were incubated for 30 min with HaloTag Alexa Fluor 488 ligand diluted in Dulbecco's modified Eagle's medium containing 10% of fetal bovine serum. Then cells were washed and incubated in Dulbecco's modified Eagle's medium for 30 min. Thereafter, cells were rinsed with PBS and stained with 1 mg/ml PI. For CRT immune staining, cells were washed twice with PBS and fixed in 0.25% paraformaldehyde in PBS for 5 min. After two additional washes in cold PBS, cells were incubated for 30 min with primary antibody, diluted in cold blocking buffer (2% fetal bovine serum in PBS), followed by washing and incubation with the Alexa488-conjugated monoclonal secondary antibody in a blocking buffer (for 30 min). Samples were then analyzed in a FACScan (Becton Dickinson) to identify cell surface CRT. Isotype-matched immunoglobulin G antibodies were used as controls, and the fluorescent intensity of stained cells was gated on PI -cells. The same staining procedure was applied to U2OS CRT-GFP-expressing cells grown on coverslips using an Alexa546 coupled secondary antibody before analysis in a Leica TCS SPE confocal microscope (Leica Microsystems, Wetzlar, Germany).
In vivo antitumor vaccination
In total, 1 Â 10 6 MCA205 cells, untreated or treated O/N with either 300 mM OXP, 150 mM CDDP, 8 mM THAPS and/or 20 mM TUNICA, alone or in combination, were injected subcutaneously into 6-week-old female C57BL/6 mice (Janvier, Charles-River, Wilmington, MA, USA) into the lower flank. In all, 5 Â 10 5 untreated control cells were inoculated into the contralateral flank 6 days later (Casares et al., 2005) . Tumor growth was evaluated for at least 50 days. All animals were maintained in specific pathogen-free conditions, and all experiments were carried out according to the Federation of European Laboratory Animal Science Association guidelines. The Ethics Committee of Institut Gustave Roussy approved all the animal experiments.
